The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05%, which ...

The United Laboratories International Holdings ( ($HK:3933) ) has issued an announcement. The United Laboratories International Holdings Limited ...

In the second part, the discussion turns to emerging DED therapies that target tear function and ocular surface homeostasis.

They're prescribed to bring much needed relief, but a new report indicates they might not have delivered what was promised.

According to IQVIA ® U.S. annual sales for cyclosporine ophthalmic emlsion 0.05% in sterile, preservative-free single-use vials for the 12 months ended September 2025 were approximately $2.0 billion.

The race to develop safer, longer lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery.

ACCORDING to Dr. J. D. Rolleston (Brit. J. Ophthal., November), no branch of medicine has a more abundant supply of folk-lore than diseases of the eye. Although ophthalmology reached a high degree of ...

Solution-state nuclear magnetic resonance (NMR) spectroscopy is the classical NMR spectroscopy approach used for molecular structure determination, where the experimental sample is studied while in ...